Labshake search
Citations for R&D Systems :
4151 - 4200 of 10000+ citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biophysics 2023Quote: ... goat anti-Cd13 (1:500, R&D Systems, AF2335); guinea pig anti-NeuN (1:500 ...
-
bioRxiv - Biophysics 2023Quote: ... and goat anti-thymopoietin (AF843, R&D Systems) primary antibodies at a dilution of 1:1000 ...
-
bioRxiv - Biophysics 2023Quote: ... and 10 ng/mL activin A (R&D Systems, cat# 338-AC) for 24 hours ...
-
bioRxiv - Biophysics 2023Quote: ... hiPSCs were primed for induction with 12 ng/mL FGF2 (R&D Systems, Cat# 233-FB) and 10 ng/mL activin A (R&D Systems ...
-
bioRxiv - Biophysics 2023Quote: ... and 10 ng/mL BMP4 (R&D Systems, Cat#: 314-BP), followed by 4 more days of FGF2 and LY294002 in CDM ...
-
bioRxiv - Biochemistry 2023Quote: ... 23 µM methylated ubiquitin (U-501-01M; R&D System, Minneapolis, MN, USA) was pre-heated at 37°C for 20 min ...
-
bioRxiv - Bioengineering 2023Quote: ... Tissue constructs were cultured in the presence of 10ng/ml TGF-β3 (human recombinant active TGF-β3, R&D Systems) for the initial 14 days ...
-
bioRxiv - Biochemistry 2023Quote: ... 5 µg/ml human MGL-Fc (R&D System) and 1 µg/ml human Dectin-2-Fc (Sino Biological ...
-
bioRxiv - Cancer Biology 2023Quote: ... CometAssay® ES II electrophoresis system (R&D systems) was used as previously described (31) ...
-
bioRxiv - Cancer Biology 2023Quote: ... NKp46 (R&D Systems cat. no AF2225; 1:200), CD45 (Novus Biologicals cat ...
-
bioRxiv - Bioengineering 2023Quote: ... The medium was supplemented with 10% fetal bovine serum (FBS, R&D Systems), 1% Penicillin/Streptomycin (Corning ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (50 ng/mL) (R&D Systems) and recombinant human interleukin-4 (IL-4 ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with 20% (v/v) FBS (R&D Systems), 1% (v/v ...
-
bioRxiv - Bioengineering 2023Quote: ... Human mesenchymal stem cells (Passage 5-7) (commercially obtained from Rooster Bio (Frederick, MD)) were cultured in hMSC growth media (R&D Systems, Minneapolis, MN, USA). Adipose-derived stem cells (Passage 3-5 ...
-
bioRxiv - Bioengineering 2023Quote: ... (Human IFN-alpha All Subtype Quantikine ELISA - R&D Systems) (Human IFN-beta DuoSet ELISA R&D Systems). cDNA was generated using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) ...
-
bioRxiv - Bioengineering 2023Quote: ... 50 ng/mL FGF2 (R&D Systems, MN, USA), 20 ng/mL BMP4 ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Bioengineering 2023Quote: ... staining for anti-murine Fatty acid binding protein 4 (Fabp4) (R&D Systems, AF1443) was used ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems). The medium was changed every 2 days ...
-
bioRxiv - Bioengineering 2023Quote: ... 1.5 mL CDM with 6 ng/mL human recombinant activin A (R&D Systems) and 5 ng/mL bFGF (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... (Human IFN-alpha All Subtype Quantikine ELISA - R&D Systems) (Human IFN-beta DuoSet ELISA R&D Systems) ...
-
bioRxiv - Bioengineering 2023Quote: VeroE6 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) (ThermoScientific, Waltham, MA, USA) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Bio-Techne, R&D systems, Minneapolis, MN, USA) and 1% (v/v ...
-
CRISPR-Cas9 Engineered Extracellular Vesicles for the Treatment of Dominant Progressive Hearing LossbioRxiv - Bioengineering 2023Quote: ... specimens were stained with anti-4 hydroxynonenal (R&D Systems MSB 3249) or anti 3-nitrotyrosine ...
-
bioRxiv - Bioengineering 2023Quote: ... and the inflammation associated proteins were found using Proteome Profiler Human Cytokine Array Kit (R&D Systems).
-
bioRxiv - Bioengineering 2023Quote: ... Proteomics were done using an established protocol from R&D Systems until the final steps ...
-
bioRxiv - Bioengineering 2023Quote: ... APC Conjugated CD31 (R&D Systems), PE Conjugated CD34 (Abcam) ...
-
bioRxiv - Bioengineering 2023Quote: ... the medium was supplemented with 100 ng/mL Noggin (R&D Systems) and 10 μM SB431542 (Fujifilm Wako ...
-
bioRxiv - Bioengineering 2023Quote: ... The angiogenesis associated proteins were found using a Proteome Profiler Human Angiogenesis Array Kit (R&D Systems) and the inflammation associated proteins were found using Proteome Profiler Human Cytokine Array Kit (R&D Systems).
-
bioRxiv - Bioengineering 2023Quote: ... or 100 ug/mL NRP-1 Antibody (R&D Systems) every other day for 5 days.
-
bioRxiv - Bioengineering 2023Quote: ECFCs and PRECs were treated with 5 nM Fc Chimera (R&D Systems) or 100 ug/mL NRP-1 Antibody (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with 10% FBS (R&D Systems, Minneapolis, MN) and 0.2% v/v plasmocin (InvivoGen ...
-
bioRxiv - Bioengineering 2023Quote: ... recombinant human fibronectin (R&D systems, Biotechne, UK); Laponite (BYK) ...
-
bioRxiv - Bioengineering 2023Quote: ... and APC Conjugated NRP-1 (R&D Systems) antibodies were added at the concentration or dilution recommended by their manufacturers and allowed to incubate for at least 30 minutes ...
-
bioRxiv - Biochemistry 2023Quote: ... 50 μM of human recombinant untagged ubiquitin (R&D SYSTEMS, U-100H) and specific human recombinant DUBs were added at the same concentration as for the proteomic experiments (800 nM) ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-cathepsin D (Cat# MAB1029) from R&D systems, and anti-EEA (Cat# 1610456 ...
-
bioRxiv - Bioengineering 2023Quote: ... 1x Penn/Strep and 10 ng ml-1 FGF9 (R&D Systems, 273-F9-025). On day 9 (metanephric mesenchyme stage) ...
-
bioRxiv - Neuroscience 2023Quote: ... Activin A levels were measured using an ELISA kit (Human/Mouse/Rat Activin A Quantikine ELISA Kit, R&D Systems, DAC00B).
-
bioRxiv - Bioengineering 2023Quote: An enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN) was used to quantify the amount of osteoprotegerin (OPG ...
-
bioRxiv - Biochemistry 2023Quote: Recombinant human angiogenin (catalog number 265-AN/CF) was purchased from R&D Systems, a Bio-Techne Company (Minneapolis ...
-
bioRxiv - Biochemistry 2023Quote: ... Single human recombinant DUBs (800 nM) were added together with 50 μM human recombinant HA-tagged ubiquitin (R&D SYSTEMS, U110) to each reaction ...
-
bioRxiv - Cancer Biology 2023Quote: ... Serum-deprived media ±recombinant human CCL8 or CCL15 (R&D Systems, Minnneapolis, MN) and ±5 μg/ml neutralizing antibodies for CCR1 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Cells were permeabilized and stained with 5 μg/ml anti-BrdU (R&D Systems). Samples were imaged with a glycerol-immersion ACS_APO 20x/NA 0.60 objective (Leica ...
-
bioRxiv - Cancer Biology 2023Quote: ... All growth factors and most small molecules used for hESC differentiation were purchased from R&D Systems. ATRA ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-NCAM1/CD56 (R&D systems, cat# AF2408), anti-Ki67 (Cell Signaling ...
-
bioRxiv - Cancer Biology 2023Quote: ... was used and for p-AXL measurements a pan-tyrosine biotinylated antibody (R&D systems BAM1676) was used ...
-
bioRxiv - Cancer Biology 2023Quote: ... HN30 and UMSCC47 cells were cultured in DMEM supplemented with 10% FBS (R&D Systems). UMSCC104 were cultured in EMEM (Quality Biological Inc ...
-
bioRxiv - Cancer Biology 2023Quote: ... NGF was purchased from R&D Systems. Q-vd-Oph was purchased from Sigma Aldrich ...
-
bioRxiv - Cancer Biology 2023Quote: ... recombinant human IL6 (206-IL-010, R&D Systems), insulin ProZinc (NDC 0010-4499-01 ...
-
bioRxiv - Bioengineering 2023Quote: ... proteins were extracted via lysis using a lysis buffer from the Proteome Profiler™ Human Apoptosis Array Kit (ARY009, R&D Systems, Minneapolis, MN) kit ...
-
bioRxiv - Bioengineering 2023Quote: ... pulled secretome for each group was profiled using a Proteome Profiler™ Human Angiogenesis Array Kit (ARY007, R&D Systems, Minneapolis, MN) following the manufacturer’s protocol ...